Emily Fairbairn - May 8, 2025 Form 4 Insider Report for IN8BIO, INC. (INAB)

Role
Director
Signature
/s/ Jason Minio, Attorney-in-Fact
Stock symbol
INAB
Transactions as of
May 8, 2025
Transactions value $
$0
Form type
4
Date filed
5/12/2025, 04:15 PM
Previous filing
Jan 6, 2025
Next filing
May 13, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
FAIRBAIRN EMILY Director C/O IN8BIO, INC., 350 5TH AVENUE, SUITE 5330, NEW YORK /s/ Jason Minio, Attorney-in-Fact 2025-05-12 0001682638

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INAB Stock Option (right to buy) Award $0 +63.2K $0.00 63.2K May 8, 2025 Common Stock 63.2K $0.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on June 8, 2025; provided, however, that the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date.